BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37816734)

  • 1. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
    Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
    Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth.
    Zhou T; Sang YH; Cai S; Xu C; Shi MH
    Cell Death Dis; 2021 Jul; 12(8):751. PubMed ID: 34326320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth.
    Li SP; Ou L; Zhang Y; Shen FR; Chen YG
    Cell Death Dis; 2023 Feb; 14(2):152. PubMed ID: 36823110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
    Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
    Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth.
    Wang Y; Ou L; Li X; Zheng T; Zhu WP; Li P; Wu L; Zhao T
    Cell Death Discov; 2022 Aug; 8(1):347. PubMed ID: 35922422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma.
    Han QC; Zhang XY; Yan PH; Chen SF; Liu FF; Zhu YR; Tian Q
    Cell Death Discov; 2021 Dec; 7(1):393. PubMed ID: 34907167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
    Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
    Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMM44 is a potential therapeutic target of human glioma.
    Guo YZ; Chen G; Huang M; Wang Y; Liu YY; Jiang Q; Cao C; Liu F
    Theranostics; 2022; 12(17):7586-7602. PubMed ID: 36438483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
    Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
    Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
    Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S
    Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondrial protein TIMM44 is required for angiogenesis in vitro and in vivo.
    Ma ZR; Li HP; Cai SZ; Du SY; Chen X; Yao J; Cao X; Zhen YF; Wang Q
    Cell Death Dis; 2023 May; 14(5):307. PubMed ID: 37147302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo.
    Mi YY; Ji Y; Zhang L; Sun CY; Wei BB; Yang DJ; Wan HY; Qi XW; Wu S; Zhu LJ
    Cell Death Dis; 2023 Jan; 14(1):67. PubMed ID: 36709328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
    Han Q; Yan P; Song R; Liu F; Tian Q
    Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
    Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
    Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.
    Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH
    Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADCK1 is a potential therapeutic target of osteosarcoma.
    Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
    Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mitochondrial ribosomal protein MRPL12 interacts directly with mitochondrial RNA polymerase to modulate mitochondrial gene expression.
    Wang Z; Cotney J; Shadel GS
    J Biol Chem; 2007 Apr; 282(17):12610-8. PubMed ID: 17337445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription-independent role for human mitochondrial RNA polymerase in mitochondrial ribosome biogenesis.
    Surovtseva YV; Shadel GS
    Nucleic Acids Res; 2013 Feb; 41(4):2479-88. PubMed ID: 23303773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Ribosomal Protein L12 Is Required for POLRMT Stability and Exists as Two Forms Generated by Alternative Proteolysis during Import.
    Nouws J; Goswami AV; Bestwick M; McCann BJ; Surovtseva YV; Shadel GS
    J Biol Chem; 2016 Jan; 291(2):989-97. PubMed ID: 26586915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mitochondrial RNA polymerase: structure-function, mechanism and inhibition.
    Arnold JJ; Smidansky ED; Moustafa IM; Cameron CE
    Biochim Biophys Acta; 2012; 1819(9-10):948-60. PubMed ID: 22551784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.